S. Barbaux et al., Accurate and rapid "multiplex heteroduplexing" method for genotyping key enzymes involved in folate/homocysteine metabolism, CLIN CHEM, 46(7), 2000, pp. 907-912
Background: Hyperhomocysteinemia, which is often associated with low folate
status, is an independent risk factor for cardiovascular diseases and seve
ral other pathologies. The four most common functional polymorphisms in gen
es involved in folate/homocysteine metabolism are methylenetetrahydrofolate
reductase (MTHFR) C677T and A1298C, methionine synthase (MS) A2756G, and c
ystathionine P-synthase (CBS) 844ins68. The pathogenic impact of these vari
ants is under active investigation in many laboratories. However, conventio
nal genotyping methods, mostly using PCR followed by restriction enzyme dig
estion, often are compromised by partial fragment digestion. There is, ther
efore, a need to develop more reliable approaches to genotyping the above p
olymorphisms that may be applied in large-scale studies.
Methods: Sequence-specific heteroduplex generators for each of the MTHFR an
d MS single nucleotide polymorphisms were generated by site-directed mutage
nesis. These were subcloned into a single construct, pHcyHG-1, which could
be multiplexed with a simple PCR amplification across the CBS 844ins68 poly
morphic site to generate composite genotype-specific banding patterns from
individual genomic DNA samples that could be electrophoretically resolved.
Results: The "multiplex heteroduplexing" method yielded unambiguous MTHFR,M
S, and CBS genotypes in a single-tube reaction that could be analyzed in a
single gel run.
Conclusions: This method permits unambiguous genotyping of the four most co
mmon functional variants of enzymes involved in folate/homocysteine metabol
ism. It is rapid, reproducible, and inexpensive, and requires no special pr
eparative or analytic facilities; consequently, it will facilitate large-sc
ale studies of the genetic basis of hyperhomocysteinemia and the many patho
logies that have been associated with this phenotype. (C) 2000 American Ass
ociation for Clinical Chemistry.